alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH

Term ID

CHEBI:146775

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactitol
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactitol
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalNAc-ol
N-[(2S,3R,4S,5R)-3-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,4,5,6-tetrahydroxyhexan-2-yl]acetamide

Definition

A glycosyl alditol derivative that is 2-acetamido-2-deoxy-D-galactitol in which the hydroxy group at position 3 has been glycosylated by an α-L-fucopyranosyl-(1→2) β-D-galactopyranosyl group.

References

glygen:G05187DJ
glytoucan:G05187DJ

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH

Human Disease Model